Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

project44 reports 34% new ARR growth driven by AI-powered supply chain solutions and Intelligent TMS expansion.

Company Fundamentals
18 May 2026
Na
View Source
Bullish
pluang ai news

project44 announced a 34% year-over-year increase in new Annual Recurring Revenue (ARR) for Q1 FY27, fueled by strong adoption of its AI agent portfolio and Intelligent Transportation Management System (TMS). The AI agents automate key logistics tasks such as freight procurement, disruption management, and carrier onboarding, delivering measurable cost savings and operational efficiencies. The acquisition of LunaPath.ai enhances multi-step workflow orchestration, advancing project44's vision of an autonomous supply chain platform. With over 160 customers using Intelligent TMS and significant improvements in freight spend, on-time performance, and data quality, project44 is solidifying its leadership in AI-driven supply chain management.

More News

Cytokinetics grants stock options and RSUs to new employees as inducements under Nasdaq rules.

Cytokinetics grants stock options and RSUs to new employees as inducements under Nasdaq rules.

Cytokinetics granted stock options for 20,807 shares and 13,793 restricted stock units (RSUs) to eight new employees who started in April and May 2026. The RSUs vest over three years, while the stock options vest over four years with an exercise pric...

Company Fundamentals
Neutral
16 minutes ago
Anthropic acquires Stainless to enhance developer tools and API connections for $300M.

Anthropic acquires Stainless to enhance developer tools and API connections for $300M.

Anthropic has acquired Stainless, a startup specializing in developer tools for APIs, for approximately $300 million. Stainless, founded in 2022, has worked with major clients including Google DeepMind, Meta, and OpenAI, and developed software linked...

Company Fundamentals
Bullish
21 minutes ago
Boston Scientific invests $1.5B for stake in MiRus, targeting advanced aortic stenosis treatment.

Boston Scientific invests $1.5B for stake in MiRus, targeting advanced aortic stenosis treatment.

Boston Scientific has invested $1.5 billion to acquire about a 34% stake in MiRus, gaining exclusive rights to its investigational transcatheter aortic valve replacement (TAVR) system designed for severe aortic stenosis. The SIEGEL valve features a n...

Market News
Bullish
1 hour ago
Elliott sees hidden value in Bio-Rad via $5B Sartorius stake amid share price slump

Elliott sees hidden value in Bio-Rad via $5B Sartorius stake amid share price slump

Activist investor Elliott Investment Management has taken a significant stake in Bio-Rad Laboratories, which develops medical instruments and software. Bio-Rad's founding family retains majority voting control, complicating activist efforts. Elliott ...

Market News
Neutral
1 hour ago
Small-cap ETFs may rebound as investors overlook them amid mega-cap tech focus, creating potential buying opportunities.

Small-cap ETFs may rebound as investors overlook them amid mega-cap tech focus, creating potential buying opportunities.

Small-cap stocks are starting to outperform again, but ETF investors remain focused on mega-cap technology and AI stocks, leading to small-cap ETFs holding only about 4% of ETF assets down from 10%. Despite $25 billion outflows from small-cap mutual ...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App